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WECHE: A Novel Hematopoietic Regulatory Factor
location (Lassila et al., 1978; Martin et al., 1978; Die-Osamu Ohneda,*k Kinuko Ohneda,*
terlein-Lievre and LeDourain, 1993; Pardanaud et al.,Hisayuki Nomiyama,² Zhong Zheng,³
1996). In addition, a number of studies have demon-Steven A. Gold,§ Fumio Arai,* Takeshi Miyamoto,*
strated that cells derived from this intraembryonic siteBruce E. Taillon,§ Richard A. McIndoe,§
are capable of long-term multilineage reconstitution ofRichard A. Shimkets,§ David A. Lewin,§
the hematopoietic system of lethally irradiated hostsToshio Suda,* and Laurence A. Lasky³k
(Godin et al., 1993, 1996; Medvinsky et al., 1993; Muller*Department of Cell Differentiation and
et al., 1994; Garcia-Porrero et al., 1995; Cuman et al.,²Department of Biochemistry
1996; Sanchez et al., 1996). In an important study, Med-Institute of Molecular Embryology and Genetics
vinsky and Dzierzak (1996) showed that isolated AGMKumamoto University School of Medicine
regions could give rise to new hematopoietic stem cells2-2-1 Honjo, Kumamoto, 860-0811
in the absence of the yolk sac, suggesting that the AGMJapan
region could produce, maintain, and, possibly, amplify³Department of Molecular Oncology
stem cells. Together, these data suggest that the in-Genentech, Inc.
traembryonic AGM region is a site where definitive stemSan Francisco, California 94080
cells are maintained in a pluripotent state.§Department of Gene Discovery
The cellular and molecular mechanisms that allow forCuraGen Corporation
the maintenance of hematopoietic stem cells are inade-New Haven, Connecticut 06511
quately understood. Morphological examination of vari-
ous embryonic hematopoietic sites revealed that hema-
topoietic progenitor cells are in close physical contact
Summary with the endothelium in both the yolk sac and the AGM
region dorsal aorta (Lin et al., 1995; Young et al., 1995;
Previously, we described AGM-derived endothelial cell Tavian et al., 1996; Wood et al., 1997; Lebastie et al.,
lines that either inhibited or permitted the development 1998). Maintenance of these pluripotent progenitor cells
of erythroid or B cells. We utilized a differential gene might thus in part be accomplished by paracrine factors
expression method to isolate a chemokine, termed produced by the endothelium, which would act upon the
WECHE, from one of these cell lines. WECHE inhibited closely juxtaposed hematopoietic cells. This possibility
the formation of erythroid cells but had no effect on has been examined by analyzing the ability of yolk sac±,
either myeloid or B cell formation. WECHE repressed fetal liver±, or AGM-derived stromal cell lines to maintain
BFU-E development from either mouse fetal liver or hematopoietic stem cells in an undifferentiated state. In
bone marrow progenitor cells but had no effect on all cases examined, the endothelium derived from yolk
colony formation induced by IL-3 or IL-7. WECHE re- sac appeared to readily induce the expansion and differ-
duced HPP-CFC production from fetal liver-derived entiation of hematopoietic progenitor cells, although the
stem cells. WECHE hindered the growth of yolk sac± ability of these endothelial cell lines to maintain the stem
derived endothelial cells. WECHE was also chemotac- cells in a pluripotent state was not carefully examined
tic for bone marrow cells. Thus, WECHE is a novel (Yoder et al., 1994; Fennie et al., 1996; Lu et al., 1996).
chemokine that regulates hematopoietic differenti- Lemischka's group demonstrated that fetal liver±derived
ation. stromal cell lines were able to maintain stem cells in
a state that allowed them to competitively repopulate
irradiated recipients (Wineman et al., 1996; Moore et al.,
Introduction
1997). However, the endothelial nature of these fetal
liver±derived stromal cell lines was not examined. Most
Hematopoietic stem cells are derived from and main- recently, Ohneda and colleagues (1998) isolated various
tained in four embryonic compartments: the yolk sac, endothelial cell lines from the murine AGM region. These
the aorta-gonad-mesonephros (AGM) region, the fetal investigators showed that one of these endothelial-like
liver, and the bone marrow (Dzierzak and Medvinsky, cell lines, termed DAS (dorsal aorta stroma) 104-4, was
1995; Zon, 1995; Peault, 1996). While stem cell reconsti- able to maintain hematopoietic stem cells in a pluripo-
tution activity has been clearly demonstrated in yolk tent state that allowed for efficient competitive repopu-
sac±derived hematopoietic cells (Yoder et al., 1997), it lation of irradiated hosts, while a second murine cell
is generally agreed that the AGM region gives rise to the line, termed DAS 104-8, induced the efficient differentia-
initial embryonic hematopoietic stem cell population, tion of hematopoietic stem cells, which was accompa-
which goes on to seed the fetal liver and adult bone nied by a loss of competitive repopulating activity. These
marrow. For example, studies in chimeric avian and am- data suggested that endothelial cell lines derived from
phibian embryos have demonstrated that the cells that the AGM region were heterogeneous, with one cell line
eventually seed the more mature hematopoietic sites inducing the maintenance of hematopoietic stem cells
are derived from an intra- but not an extraembryonic in a pluripotent state.
The results of Ohneda and colleagues (1998) sug-
gested that the DAS 104-4 endothelial cell line mightk To whom correspondence should be addressed (e-mail: oohneda@
kaiju.medic.kumamoto-u.ac.jp and lal@gene.com). produce a factor(s) that inhibited the differentiation of
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hematopoietic progenitor cells. Alternatively, it is possi- novel protein also contained an extended C-terminal
domain of approximately 65 amino acids. This C-termi-ble that the DAS 104-8 cell line produced a factor(s) that
stimulated the differentiation of these pluripotent cells. nal region does not appear to encode a known functional
domain, and it does not appear to be significantly homol-In order to examine these possibilities, a unique differen-
tial gene expression technique, GeneCalling, was uti- ogous to other proteins in the current databases. The
fact that this novel protein appears to be only distantly re-lized to examine the mRNA transcripts in each of these
cell lines (Shimkets et al., 1999). This resulted in the lated to known CXC chemokines, together with the highly
unusual C-terminal extension of the protein, prompted usisolation of a novel endothelial-associated chemokine
that appeared to inhibit erythroid differentiation and pro- to coin the name WECHE (WEird CHEmokine) for this
differentially expressed protein. The WECHE gene (genegenitor cell expansion. These findings suggest that en-
dothelial-derived factors such as this novel chemokine symbol Scyb15) was placed on the central part of the
linkage map of mouse chromosome 5 in a position wemight act as suppressors of differentiation in the embry-
onic AGM region. estimated to be 51 cM offset from the centromere based
on comparing our mapping data to values in the com-
posite map in the Mouse Genome Database (Figure 1)Results
(http://www.informatics.jax.org). WECHE (Scyb15) was
found to cosegregate with the CXC chemokine GroIsolation of a Novel Chemokine Using
(Gro1) and MIP-2 (Mip2) genes in all 94 animals analyzedDifferential Display
(data not shown), suggesting tight linkage. Three otherThe divergent stem cell maintenance activities of the
CXC chemokine genes for IP-10 (Ifi10), Mig (Mig), andDAS 104-4 and DAS 104-8 cells suggested that these
LIX (Scyb5) are also mapped in this same BSS crosslines might be useful for differential display analysis of
and are located 2.1 cM distal of the Weche(Scyb15)/mRNA transcripts (Ohneda et al., 1998). A novel differen-
Gro1/Mip2 locus. These results suggest that WECHEtial gene expression analysis method was therefore uti-
is a novel and unusual CXC type of chemokine thatlized on these cell lines to investigate transcripts that
is expressed at significant levels in the stem cell±were upregulated in the stem cell±maintaining cell line,
maintaining DAS 104-4 cell line.DAS 104-4, as compared with the differentiation-induc-
Northern and PCR analyses were next undertaken toing cell line, DAS 104-8 (Shimkets et al., 1999). This novel
examine the in vivo expression of the WECHE chemo-display procedure essentially involves the examination
kine. In order to confirm the differential expression of theof diverse fluorescently labeled cDNA transcripts by a
mRNA encoding this chemokine, Northern blot assayshigh-resolution gel sizing technique and comparing the
were performed using RNA isolated from the DAS 104-4levels of expression of variously sized fragments in each
and DAS 104-8 cell lines. Figure 2A illustrates that, ascell line. Fragments that show differential expression
predicted from GeneCalling (Figure 1), a significantlylevels are further analyzed by polymerase chain reaction
higher level (z20-fold) of both transcripts encoding(PCR) amplification, cloning, and sequencing to identify
WECHE are found in the DAS 104-4 versus the DASgenes that may encode proteins of potential interest.
104-8 cell line. This figure also illustrates that WECHEFigure 1 illustrates a trace from a region that contains
such a differentially expressed gene fragment. As can is only expressed at detectable levels in adult lung. In
addition, the WECHE transcripts are not observable inbe seen from this figure, the traces show a diversity
of fluorescently labeled cDNA bands that have been early embryonic tissues and only become visible in day
17 embryo RNA (data not shown). While it is possibleseparated according to size. These traces illustrate that
most of these transcripts are expressed at approxi- that these two transcripts encode differentially spliced
WECHE protein species, PCR analyses have revealedmately equal levels in the DAS 104-4 and 104-8 cell
lines. However, the transcript that migrates at position that alternative polyadenylation is the likely explanation
for these diverse species. The PCR data shown in Figure214.0 (highlighted by the red line) appears to be signifi-
cantly more expressed in the DAS 104-4 cell line as 2B confirms the Northern blot information shown in Fig-
ure 2A. In addition, this figure demonstrates that WECHEopposed to DAS 104-8. These results suggest that if the
gene associated with this fragment encodes a protein, is expressed at significant levels in day 10.5 yolk sac and
day 10.5 AGM regions, both sites of stem cell productionit should also be expressed at a higher level in the DAS
104-4 cell line than in the DAS 104-8 cell line. and maintenance. Interestingly, the transcript is not de-
tectable in fetal liver between 11.5 and 13.5 days ofSequencing of the differentially expressed transcript
illustrated in Figure 1 revealed that it encoded a partial development, a time when significant stem cell mainte-
nance is occurring in this organ (although the transcriptsequence that was homologous to several chemokines
of the CXC (a) family (Rollins, 1997). Figure 1 illustrates is detectable when further PCR cycles are performed).
The observation that WECHE is expressed in the AGMthat the protein encoded by the full-length transcript
(predicted molecular weight » 17 kDa) is indeed a novel region at a time when this site produces and maintains
hematopoietic stem cells is consistent with the isolationmember of the CXC chemokine family. Comparison of
this protein with other members of this family revealed of this cDNA from a cell line derived from this region,
and it also suggests a potential in vivo role for thisthat there were no close relatives of this chemokine,
suggesting that this novel protein is a new type of CXC chemokine in hematopoietic development. Finally, the
WECHE transcript was not detected in whole bone mar-chemokine. As with many chemokines in the CXC family,
this novel protein contained an ELR (Glu-Leu-Arg) se- row RNA, although this may have been due to expres-
sion of the RNA on only a small subset of cells (dataquence near its N terminus, a feature that has previously
been shown to be required for receptor binding. How- not shown).
Immunohistochemistry of various murine embryonicever, in stark contrast to other CXC chemokines, this
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Figure 1. Transcript Analysis of Poly(A) RNA Isolated from DAS 104-4 and DAS 104-8 Cell Lines and Identification of a Differentially Expressed
Chemokine
(A) Illustrated are tracings of fluorescently labeled transcripts produced by GeneCalling (Shimkets et al., 1999) of poly(A) RNA from two different
cell lines isolated from the AGM region of day 11 murine embryos (Ohneda et al., 1998). Both plots show triplicate samples (blue, red, and
green tracings) of electrophoretically sized transcripts. The transcript derived from the DAS 104-4 cell line migrating at position z214 (highlighted
by the red line) is expressed at significantly lower levels in the DAS 104-8 cell line (z20 fold). The levels of other transcripts appear to be
remarkably similar in the two cell lines.
(B) Shown is the complete protein sequence corresponding to the differentially expressed partial transcript migrating at position z214 of
Figure 1. This protein, termed WECHE (WEird CHEmokine), is related to members of the CXC class of chemokines, including IL-8. As can
be seen, WECHE contains an ELR sequence after the N-terminal signal sequence as well as other residues conserved with CXC-like chemokines.
The figure also illustrates that WECHE contains an extended C terminus, although this region is not significantly homologous to any sequences
or domains in the current databases (data not shown).
(C) The dendrogram illustrates that WECHE is only distantly related to any of the known chemokines and appears to be a novel family member.
(D) Chromosomal localization of the WECHE gene. (a) Linkage map of the Jackson BSS backcross showing the mouse chromosome 5 around
the Weche (Scyb15) locus. The centromere is toward the top. A 3 cM scale is shown on the right. (b) Haplotypes of the Weche locus and the
flanking markers of the 94 Jackson Laboratory BSS backcross animals studied. The black boxes represent the C57BL6/Ei allele, and the
white boxes represent the SPRET/Ei allele. The number of animals with each haplotype is shown at the bottom of the column of boxes. The
percentage recombination (R) between adjacent loci is given to the right of the figure, with the standard error (SE) for each R.
stages using affinity-purified anti-WECHE polyclonal an- in the yolk sac at this stage. Higher magnification analy-
sis of the AGM and yolk sac regions of the day 10.5tibody was performed to determine regions of WECHE
expression during development. Figure 3 illustrates that embryo revealed that the endothelium of the dorsal aorta
and cells resembling the pericytes of the yolk sac bloodthe endothelium of the dorsal aorta of the day 9.5 embryo
was positively stained with WECHE antibody, while no islands expressed WECHE antigen (Figures 3Ad and
3Bc). In day 12.5 embryos, specific staining was de-specific positive staining was observed in the embryo
stained with control rabbit IgG. Expression of WECHE tected in the midbrain and somites (Figure 3C). In addi-
tion, weaker but apparently specific staining was alsoin the dorsal aorta is consistent with its expression in
the 104-4 cell line, which was presumably isolated from observed in the fetal liver, suggesting that the lack of
PCR signal detected using fetal liver RNA may havethis embryonic site in the AGM region (Ohneda et al.,
1998). Interestingly, patchy staining was also observed been due to low transcript concentration (use of higher
Immunity
144
weight of the purified protein, z24 kDa, was consistent
with glycosylation as well as the inclusion of the C-ter-
minal extension, suggesting that this region is not pro-
teolytically removed under these culture conditions
(data not shown).
Analysis of the 104-4 stromal cell line by Ohneda and
colleagues (1998) demonstrated a significant inhibition
of both erythroid as well as B cell production in response
to exogenous growth factors, while the 104-8 cell line
showed no such inhibitory activity. In order to investi-
gate the potential role of WECHE in these activities, the
purified protein was added to cultures containing fetal
liver hematopoietic stem cells and a DAS 104-8 stromal
cell layer. Figure 4A illustrates that the WECHE protein
was capable of inhibiting erythroid development but did
not affect myeloid or B cell development. Because only
low levels of erythroid and B cell development were
observed in the absence of exogenous growth/differen-
tiation factors, the inhibitory activity of WECHE on EPO-
or IL-7-induced differentiation was also investigated. As
Figures 4B and 4C show, WECHE inhibited the differenti-
ation of erythroid cells in response to EPO but had no
effect on IL-7-induced B cell differentiation. Interest-
ingly, WECHE also appeared to reduce the total number
of nonadherent cells produced when fetal liver stem
cells were incubated on DAS 104-8 stromal cells (Figure
4D), which is consistent with an inhibitory effect on the
proliferation of a relatively early progenitor cell as well asFigure 2. Transcript Analysis of WECHE Expression
on erythroid development. Together, these data suggest(A) Shown are Northern blots analyzing WECHE expression in vari-
ous cells and tissues. The left blot illustrates that WECHE is ex- that WECHE specifically inhibits erythroid differentiation
pressed at significantly higher levels in the DAS 104-4 (A) versus while leaving myeloid and B cell differentiation intact in
the DAS 104-8 cell line (B), which is consistent with the differential these in vitro stromal cell culture conditions. While the
display analysis illustrated in Figure 1. In addition, WECHE is ex- results shown in Figure 4 suggested that WECHE hin-
pressed at detectable levels only in adult lung (F) and is not ex-
dered erythroid production as well as total nonadherentpressed in heart (C), brain (D), spleen (E) liver (G), skeletal muscle
hematopoietic cell expansion, they did not address the(H), nor kidney (I).
effect of the protein on the colony-forming activity of(B) PCR analysis of WECHE expression confirms that WECHE is
highly expressed only in the DAS 104-4 cell line and in adult lung. hematopoietic progenitor cells. Figure 5A shows that
In addition, analysis of embryonic RNA illustrates that WECHE is WECHE also inhibited the number of high±proliferative
expressed at low levels in day 10.5 yolk sac and in days 10.5 and potential colony-forming cells (HPP-CFC). This result
11.5 AGM region. The latter result is significant because this is the was consistent with the hypothesis that WECHE inhib-
region that gave rise to the DAS 104-4 cell line. Amplification of
ited a relatively early progenitor cell type. Analysis ofG3PDH was used as an internal control for cDNA quality and PCR
early (BFU-E) and late (CFU-E) erythroid progenitor cellsefficiency in each lane.
revealed that WECHE inhibited the growth of BFU-E
from both fetal liver (FL) and bone marrow (BM), while
in CFU-E only the growth of bone marrow was affectedPCR cycles showed transcript in this organ [data not
by WECHE. As with the HPP-CFC results, these datashown]). Finally, staining was observed on the umbilical
suggested that WECHE acted on a relatively early pro-vein and the bladder. Together, these data suggest that
genitor to inhibit erythroid production. Finally, in agree-WECHE is expressed in the dorsal aorta and yolk sac
ment with the stromal cell studies shown in Figure 4,as well as a diversity of unexpected sites including the
WECHE had no effect on colony formation induced byfetal liver, bladder, and umbilical vein.
either IL-3 or IL-7, which is consistent with the sugges-
tion that WECHE affects the differentiation of the ery-
WECHE Modulates Hematopoietic Development throid lineage in a relatively specific manner. Together,
Previous data from Ohneda and colleagues indicated these results suggest that WECHE acts to inhibit the
that the DAS 104-4 cell line inhibited erythroid and B cell differentiation and/or proliferation of a relatively early
development in response to EPO and IL-7, respectively erythroid progenitor population.
(Ohneda et al., 1998). In order to examine the potential Early hematopoietic and endothelial progenitors are
role of the WECHE chemokine as an inhibitor of hemato- thought to be derived from a common precursor cell,
poietic differentiation, the protein was produced by and the hemangioblast. In order to determine if WECHE
isolated from supernatants of SF9 insect cells. Analysis might have an effect on the proliferation of endothelial
of the N terminus of the purified protein demonstrated progenitors, cells were harvested from either the yolk
that the signal sequence was cleaved before glutamine sac or the AGM region and were incubated with VEGF
on OP9 stromal cells in the presence of increasing levelsresidue 19 (data not shown). In addition, the molecular
A Novel Hematopoietic Regulator
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Figure 3. WECHE Immunohistochemistry in
the Early Embryo
Immunostaining with affinity-purified anti-
WECHE antibody of the embryos at 9.5 dpc
(A), 10.5 dpc (B), and 12.5 dpc (C).
(A) Embryos at 9.5 dpc were stained with
anti-WECHE antibody ([a] right) or isotype-
matched IgG ([a] left). High magnification of
embryo stained with anti-WECHE antibody
is shown in (b). White arrowheads indicate
dorsal aorta region (a and b). Sagittally sec-
tioned embryos stained with normal rabbit
IgG or anti-WECHE antibody (d) were coun-
terstained with nuclear fast red. Black arrow-
heads indicate positively stained elongated
endothelial-like cells in the dorsal aorta
(DA) (d).
(B) The yolk sac in the square area was
patchly stained with anti-WECHE antibody
(a). High magnification of yolk sac is shown
in (b). Sagittal section of the yolk sac showing
that cells surrounding the endothelium were
positive ([c] black arrowheads).
(C) Fetal liver (square area), spinal nerves,
and cartilage primordium of vertebra (white
asterisk and white arrowheads, respectively)
were positively stained with anti-WECHE antibody (a±c). High magnification of fetal liver or cartilage primordium of vertebra (b and c) is shown.
Umbilical veins (UV) and the surface of the bladder (Bl) were also positively stained with anti-WECHE antibody in a different sectioned sample
(d). Isotype-matched control antibodies showed no staining in any sections.
of WECHE. The number of cell clusters positive for WECHE Is Chemotactic for Bone Marrow
Progenitor CellsCD31, an endothelial marker, was determined after 10
days in culture. As illustrated in Figure 6, WECHE ap- Previous studies have highlighted the ability of chemo-
kines such as the B cell modulation factor SDF-1a topeared to inhibit endothelial cell cluster formation when
endothelial cells were isolated from the yolk sac but not induce a chemotactic response in hematopoietic pro-
genitor cells (Aiuti et al., 1997; Kim and Bronxmeyer,from the AGM region. In addition, this inhibitory activity
was neutralized by a polyclonal antibody directed against 1998; Kim et al., 1998). In order to examine the ability
of WECHE to mediate chemotaxis, bone marrow cellsthe WECHE protein. These results suggest that WECHE
may affect not only hematopoietic cell growth and differ- were incubated with increasing quantities of the chemo-
kine in Transwell cultures. Figure 7 illustrates thatentiation but also the growth and differentiation of some
endothelial cells. WECHE attracted bone marrow progenitor cells in a
Figure 4. WECHE Inhibits Stem Cell Differen-
tiation and Hematopoietic Cell Proliferation
on DAS 104-8 Stromal Cell Layers
Fetal liver stem cells (13.5 day; 2 3 103 cells)
(lin2Sca1c-Kit1) were cultured on the DAS
104-8 stromal cell line without (A) or with cyto-
kines (EPO or IL-7) (B and C) in the presence
of WECHE. The frequency of lineage-positive
cells was analyzed by FACS on day 6 (A and
B) or day 11 (C) using MAC-1/GR-1 (myeloid),
B220 (lymphoid), or TER-119 (erythroid) lin-
eage-specific monoclonal antibodies. Total
nonadherent cells on DAS 104-8 cell were
harvested after 10 days of incubation, and




Figure 5. WECHE Inhibits Hematopoietic Pro-
genitor Cell Differentiation along the Ery-
throid Pathway
(A) Erythroid progenitor cells were harvested
from 13.5 day fetal liver (FL, left) or adult bone
marrow (BM, right), and 2 3 104 cells were
cultured in methylcellulose culture medium
with erythropoietin (EPO) for 2 days (CFU-E)
or 8 days (BFU-E) in the presence of WECHE.
Erythroid colonies were stained with benzi-
dine, and the number of benzidine-positive
(hemoglobinized) colonies was scored.
(B) Cells (2 3 104) derived from adult bone
marrow cells were cultured with methylcellu-
lose in the presence of WECHE with IL-3 or
IL-7. The number of IL-3- or IL-7-dependent
colonies was scored on day 8.
(C) Fetal liver stem cells (13.5 day; 2 3 104
cells) (lin2Sca1c-Kit1) were cultured in meth-
ylcellulose culture medium for 14 days in the
presence of WECHE, and the number of HPP-
CFC was counted.
dose-dependent manner, with peak levels of chemo- Discussion
taxis that were comparable to those observed with
the SDF-1a chemokine. In addition, the typical ªbell- The maintenance of hematopoietic stem cells through-
out the life of the organism is an important physiologicalshapedº response to increasing chemokine concentra-
tions was observed. This figure also shows that the mechanism that insures a constant supply of mature
blood cell lineages (Morrison et al., 1997). Stem cellspolyclonal antibody directed against the WECHE protein
was able to inhibit this activity. These data suggested appear to exist in a milieu that exposes them to constitu-
tive levels of factors that induce them to differentiatethat, as has been observed with other hematopoietic
regulatory chemokines, WECHE is able to induce a che- down a diversity of pathways. One mechanism to main-
tain a subset of these progenitor cells in a pluripotentmotactic response in hematopoietic progenitor cells.
state would be to prevent their differentiation in an in-
structive manner (Morrison and Weissman, 1994). This
might be accomplished by additional uncharacterized
hematopoietic regulatory factors that would inhibit the
progression toward diverse mature lineage pathways.
It is expected that such factors would be produced by
stromal cells in various hematopoietic sites, since these
cells appear to be in close contact with hematopoietic
stem cells (Young et al., 1995; Tavian et al., 1996; Wood
et al., 1997). In order to isolate such instructive differenti-
ation inhibitory factors, we and others have character-
Figure 6. WECHE Inhibits VEGF-Induced Endothelial Cell Growth
on OP9 Stromal Cell Line
The effects of WECHE on the expansion of endothelial cells from
different hematopoietic organs was examined in vitro using the OP9
stromal cell line and the endothelial growth factor VEGF. Yolk sac
cells from 9.5 day embryos were harvested, and 2 3 104 cells were
cocultured with the OP9 stromal cell line in the presence of VEGF
(10 ng/ml) and WECHE (left). Endothelial cells [FLK-11CD31
(PECAM-1)1] were isolated by FACS from 10.5 day yolk sacs or
AGMs. Seven hundred fifty cells from yolk sac (open squares) or
250 cells from AGM (closed circles) were cocultured with the OP9
Figure 7. Analysis of Chemotactic Activity of WECHEstromal cell VEGF (10 ng/ml) and various concentrations of WECHE
(right). Four micrograms per milliliter of affinity-purified anti-WECHE Cells (5 3 105) from adult bone marrow were plated into transwells
(5 uM pore size), and the number of migrated cells was countedantibody was added to the culture with 200 ng/ml of WECHE (right,
closed square). After 10 days of cultivation, cells were fixed and under a microscope after 4 hr incubation with WECHE (left). Four
micrograms per milliliter of anti-WECHE antibody was added to thestained with anti-PECAM-1 antibody, which specifically detects en-
dothelial cells. The number of PECAM-1-positive endothelial cell culture with WECHE (500 ng/ml), and 500 ng/ml of SDF-1a was used
as a positive control (right).clusters was scored.
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ized embryonic and adult hematopoietic site derived± The hematopoietic modulatory activity of WECHE ap-
pears to be somewhat different from that previouslystromal cell lines that are capable of stem cell mainte-
described for other chemokines. Most notably, this che-nance (Wineman et al., 1996; Moore et al., 1997; Ohneda
mokine seems to specifically affect the differentiationet al., 1998). One such cell line derived from the embry-
of the erythroid lineage of progenitor cells and has littleonic AGM region, termed DAS 104-4, inhibits erythroid
effect on the lymphoid or myeloid lineages. This sug-and lymphoid cell differentiation and maintains hemato-
gests that other proteins may be involved with the sup-poietic stem cells in a pluripotent state (Ohneda et al.,
pression or the differentiation of other lineages in the1998). It is thus of significant interest that WECHE, a
AGM region. For example, two recently described hu-novel chemokine that we describe here, is expressed
man chemokines, MPIF-1 and MPIF-2, appear to specifi-by this AGM-derived stromal cell line and is capable
cally inhibit the production of mature myeloid coloniesof inhibiting erythroid but not myeloid or lymphoid cell
in methylcellulose cultures, suggesting that differentdifferentiation (Ohneda et al., 1998).
chemokines may have differential inhibitory effects onVarious chemokines have been previously found to
diverse hematopoietic cell lineages (Patel et al., 1997).regulate aspects of hematopoiesis. For example, the
The mechanism by which WECHE suppresses erythroidSDF-1a CXC chemokine has been shown to be involved
development specifically is currently unclear. The re-with B cell development and myelopoiesis (Nagasawa
sults reported here cannot differentiate between effectset al., 1994). A significant finding is that animals that were
on the proliferation of progenitor cells or the differentia-made deficient for the SDF-1a expression appeared to
tion of these cells. One possible reason for this specific-have defects in B cell and myeloid production (Naga-
ity may reside in the unusual C-terminal extension thatsawa et al., 1996). Initially, it appeared that these effects
is found on this protein. While a few other chemokines,might be mediated by growth stimulation of hematopoi-
such as neurotactin/fractalkine (Bazan et al., 1997; Panetic progenitors. Recently, it has been suggested that
et al., 1997), have extended C termini, this type of elon-these effects may in part be mediated by the ability of
gation is unusual. The augmented C terminus of WECHEthis chemokine to retain progenitor cells in the appro-
may activate receptors on erythroid progenitor cells inpriate hematopoietic microenvironment (Aiuti et al.,
a specific manner that might send anti-proliferative/dif-1997; Kim and Bronxmeyer, 1998; Kim et al., 1998). Thus,
ferentiation signals to the cell. This hypothesis is notmice reconstituted with fetal liver cells deficient in the
without precedent, as truncation of the elongated Cexpression of the SDF-1a receptor, CXCR4, showed
terminus of lymphotactin resulted in a loss of chemotac-decreased B cell progenitors in bone marrow and in-
tic activity, possibly due to changes in the protein'screased numbers in the periphery (Kawabata et al., 1999;
structure (Hedrick et al., 1997). An important test of thisMa et al., 1999). Interestingly, these effects were not
hypothesis will be to examine the activities of C-termi-observed on the erythroid and megakaryocyte lineages,
nally truncated versions of WECHE on the inhibition ofsuggesting that chemokines such as SDF-1a might have
erythroid differentiation.differential effects on different progenitor cell popula-
The inhibitory activity of WECHE on the proliferationtions. In studies more germane to those described here,
of HPP-CFC and total nonadherent cell production ina number of CXC and CC chemokines have been found
stromal cell cultures suggests that this chemokine isto have inhibitory activities on the differentiation of
capable of acting upon relatively early progenitor cells,hematopoietic progenitor cells. For example, MIP1a,
since stem cells highly purified from fetal liver were usedGRO-b, PF4, IL-8, MCP-1, IP-10, and CCF18 have all
for these assays. Similar activities have been describedbeen found to suppress colony formation of all progeni-
for the MPIF-2 CC chemokine, but this chemokine inhib-
tor cell types in methylcellulose assays (Rollins, 1997).
ited myeloid and not erythroid progenitors, suggesting
These inhibitory activities appeared to act directly on
that it may act in a different manner than the WECHE
the CD34-positive progenitor cell, although it is difficult chemokine (Patel et al., 1997). However, these data to-
to determine if the activity is due to a block in prolifera- gether suggest that chemokines may affect the prolifera-
tion, differentiation, or both (Verfaille, 1996). As far as tion or differentiation of early progenitor cells, perhaps
effects on hematopoietic stem cells, MIP1a seems to even stem cells. This latter hypothesis is supported by
inhibit stem cell proliferation in vitro and in vivo (Dunlop data that demonstrate that MIP1a appears to be in-
et al., 1992; Mayani et al., 1995; Verfaille, 1996). In addi- volved at least with the maintenance of a very early
tion, this chemokine appears to protect these progenitor hematopoietic progenitor cell in culture (Verfaille et al.,
cells from the effects of cytotoxic agents in vivo, possi- 1994). While the inhibition of production of HPP-CFC
bly by blocking proliferation of these progenitor cells does not prove that WECHE is inhibiting stem cell differ-
(Lord et al., 1992; Quesniaux et al., 1993). However, entiation, it is consistent with this hypothesis. Thus, one
mice with a null mutation of this chemokine show no possible reason for the expression of WECHE in the
hematopoietic defects but instead exhibit effects on the AGM and yolk sac regions is for it to act as a factor that
inflammatory response against viral infections, sug- helps to maintain early progenitor cells by inhibiting their
gesting a role for this chemokine as an inflammatory- differentiation.
induced chemoattractant (Cook et al., 1995). More re- The nature of the receptor involved with the hemato-
cently, two novel CC chemokines have been shown to poietic regulatory activity of WECHE remains unknown.
specifically inhibit growth of myeloid progenitors (Patel Attempts to bind WECHE, an IL-8 related chemokine,
et al., 1997). Together, these data suggest that chemo- to the known human IL-8 receptors, CXC R1 and CXC
kines are capable of modulating hematopoietic progeni- R2 were unsuccessful (O. Yoshie, personnal communi-
cation). This could be due to a number of reasons. Fortor activity in a number of different manners.
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on a product using a multicolor laser excitation Niagara (CuraGen)example, we have been unable to characterize a human
imaging system. The data obtained from Niagara gels were queriedhomolog of the WECHE protein using low stringency
against public and proprietary databases (Shimkets et al., 1999). ASouthern and Northern blotting and analyses of various
partial sequence for the N terminus of WECHE was detected in a
human cDNA databases (data not shown). This suggests differentially expressed transcript, and the IMAGE Consortium clone
that if there is a functional homolog of WECHE in hu- encoding the sequence was obtained and the entire coding se-
quence determined. This cDNA clone was used for subsequentmans, this protein is likely to be quite divergent. Thus,
analyses. WECHE protein was produced as a C-terminal His-taggedit might be expected that the murine protein may be
molecule using baculovirus expression in SF9 insect cells. The se-unable to bind to the human receptor, since the murine
creted protein was affinity purified using nickel-agarose affinityIL-8-like receptor is homologous (z70%) to the human
chromatography. The protein was shown to be free of endotoxin.
ortholog receptors (Rollins, 1997). An alternative possi-
bility, which is far more interesting, is that the WECHE Mice and Antibodies
chemokine binds to a novel receptor that is involved with Timed pregnant mice (C57BL/6) or 2- to 3-month-old male mice
(C57BL/6) were purchased from Japan SLC (Shizuoka, Japan). Micehematopoietic regulation. This latter possibility would
were sacrificed by cervical dislocation. The antibodies used forsuggest that WECHE may interact with a unique recep-
stem cell sorting were all obtained from PharMingen. Biotinylatedtor(s) that might be expressed on earlier hematopoietic
antibodies for lineage cocktail contain anti-CD4 (GK1.5), anti-CD8progenitor cells. The resolution of this question will obvi-
(53-6.7), anti-B220 (6B2), anti-Gr-1 (8C5), and anti-erythroid (TER119).
ously require the characterization of the receptor(s) that Other antibodies include phycoerythrin (PE)-conjugated anti-Sca-1
is activated by WECHE. antibody (E13) and fluorescein (FITC)-conjugated anti-c-Kit antibody
(2B8). Secondary reagent includes allophycoerythrin (APC)-labeledIn closing, the isolation and characterization of the
streptavidin (Caltag Laboratories). The antibodies used for isolationWECHE chemokine suggest that this protein may func-
of endothelial precursor cells were PE-conjugated anti-CD45 anti-tion as a modulator of erythroid cell development in the
body (Ly-5) (clone, 30-F11) (PharMingen), FITC-conjugated anti-hematopoietic microenvironment. While this manuscript
CD31 antibody (PECAM-1) (clone, MEC13.3) (PharMingen), and
was being prepared, Rossi and colleagues described biotinylated anti-Flk-1 antibody. All isotype-matched rat immuno-
the cloning and analysis of a chemokine identical to globulins were obtained from PharMingen. Anti-WECHE antibody
was produced in rabbits and guinea pigs using an E. coli±producedWECHE, which they termed Lungkine (Rossi et al., 1999).
GST fusion protein containing the entire WECHE sequence. Antibod-Lungkine appears to be expressed in lung epithelial
ies were affinity purified using the immunogen.cells, and its expression is modestly enhanced by vari-
ous inflammatory stimuli. In addition, this chemokine
Cell Linesappeared to be a chemoattractant for neutrophils, al-
E11 mouse dorsal aorta±derived stromal (DAS) cell lines (DAS 104-4
though this chemoattraction only occurred at relatively and DAS 104-8) and b-End3 cell line were maintained in HAVA me-
high concentrations and was quite weak. Interestingly, dium (Dulbecco's modified Eagle's medium: DMEM [GIBCO±BRL])
supplemented with 0.1 mM nonessential amino acids (GIBCO±BRL),Lungkine was found in the bronchiolar lavage, sug-
2 mM L-glutamine (GIBCO±BRL), 0.1 mM b mercaptoethanol (Sigma),gesting a role for this chemokine as a chemoattractant
and penicillin-streptomycin containing 10% fetal bovine serumfor leukocytes to this region of the lung. Importantly, our
(FBS) (JRH Bioscience). The OP9 stromal cell line (generously pro-immunohistochemical analysis of embryonic WECHE
vided by H. Kodama, Bayer Yakuhin, Kyoto, Japan) was isolated
expression suggests possible roles for this protein in from newborn calvaria and is maintained in a modified minimum
other developmental pathways, including hematopoi- essential media (a-MEM) (GIBCO±BRL) supplemented with 20%
FBS.etic, muscle, and neuronal sites. Together with the data
reported here, the work on Lungkine suggests that this
Analysis of Expression of Weche mRNA by Reversemolecule may play diverse roles in developmental, in-
Transcriptase-Polymerase Chain Reactionflammatory, and hematopoietic physiology. It will be
and Northern Blot Analysisimportant to analyze the effects of in vivo overexpres-
Total RNA was prepared from DAS cell lines or mice tissues by
sion of WECHE/Lungkine as well as the loss of expres- using RNA isolation reagent (Trizol, GIBCO±BRL). RNAeasy mini kit
sion of this protein on these physiological processes. (Qiagen GmbH, Hilden, Germany) was used to isolate total RNA
from fractionated hematopoietic cells. One microgram of total RNAIn addition, the role of the C-terminal extension in hema-
was reverse transcibed using the Reverse Transcriptase-Polymer-topoietic activity as well as the type of murine receptor(s)
ase Chain Reaction kit (Clontech Laboratories). cDNAs were ampli-activated by WECHE/Lungkine should provide impor-
fied by GeneAmp PCR system model 9700 (Perkin-Elmer) for 25 totant new information. Finally, the effects of WECHE/
30 cycles using the following conditions: 5 s at 948C for denaturation
Lungkine on stem cell maintenance may provide insights and 3 min at 688C for annealing/extension. PCR reactions were
into the role of this chemokine in the preservation of the electrophoresed on 1% agarose gels, stained with ethidium bro-
mide, and examined. The PCR primers were as follows: weche-59,pluripotent state of hematopoietic progenitor cells.
59 -AATTCTCGAGTCGCGAATGGCTGCTCAAGGCTG-39; weche-39,
59 -ATTACGGCCGTCGCGATTAGGCATCACTGCCTG-39; b-actin-59,Experimental Procedures
59-TCGTGCGTGACATCAAAGAG-39; b-actin-39, 59 -TGGACAGTG
AGGCCAGGATG-39; G3PDH-59, 59 -TGAAGGTCGGTGTGAACGGDifferential Gene Expression Analysis, cDNA
ATTTGGC-39; and G3PDH-39, 59 -CATGTAGGCCATGAGGTCCACCharacterization, and Protein Production
CAC-39. Northern blots were performed using total RNA derivedGeneCalling reactions were performed essentially as described
from DAS cell lines and commercially available mouse tissue blots(Shimkets et al., 1999). Briefly, double-stranded DNA was digested
and the WECHE cDNA as probe.using pairs of 4 base pair recognition sites. Seventy-five enzyme
pairs were used and were chosen such that a representative cover-
age of most of the possible sequences in a given DNA sample was Immunohistochemistry
Whole embryos or microsliced embryos (400 mm thick) were fixedachieved. PCR amplification using specific linkers was carried out as
previously described (Shimkets et al., 1999). The final DNA products with 4% paraformaldehyde in PBS for 2 hr at 48C. Endogenous
peroxidase activity was quenched with 5% hydrogen peroxide inwere denatured and electrophoresed on polyacrylamide gels in 6
M urea. PCR products were visualized by the presence of FAM label methanol overnight at 48C. After washing with PBS, the embryos
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were incubated with blocking buffer (1% normal goat serum CD451CFLK11 PECAM-11 cells (750 or 250) from yolk sac or AGM,
respectively, were plated on OP9 cells and cultured with 10 ng/ml[GIBCO±BRL]/0.2% BSA in PBS:2% skim milk [Difco Laboratories] in
PBST [0.1% Tween 100 in PBS] 5 1:4) for 2 hr at 48C. Subsequently, of VEGF for 10 days. Cultured cells were fixed with 4% paraformal-
dehyde and stained with anti-PECAM-1 antibody. After beingembryos were incubated with anti-WECHE antibody (1 mg/ml) or
normal rabbit IgG (1 mg/ml) (Jackson Immunoresearch) in blocking washed several times, HRP-conjugated goat anti-rat IgG antibody
was added and incubated with substrate. The number of PECAM-11buffer overnight at 48C. After extensive washing with 2% skim milk
in PBST, embryos were incubated with HRP-conjugated goat anti- clusters was counted under a microscope.
rabbit Ig antibody (Biosource) (1:400 dilution in 2% skim milk in
PBST) overnight at 48C. After the final wash, embryos were soaked Analysis of Chemotactic Activity
with PBST containing 250 mg/ml of diaminobenzidine and 0.05% Adult BM cells were harvested and passed through Sephadex G-10
of NiCl2 for 10±30 min at room temperature. 0.01% hydrogen perox- (Amersham Pharmacia Biotech) to eliminate adherent cells, includ-
ide was added to the samples for color reaction. ing stromal cells. Nonadherent cells were incubated in Iscove's
modified Dulbecco's medium (IMDM)/0.5% BSA (Sigma) for 15 min
Differentiation of Hematopoietic Stem Cells on DAS 104-8 Cells at room temperature. Cells (5 3 105) in 100 ml of IMDM/0.5% BSA
E13.5 mouse fetal livers were harvested, and single cells were ob- were plated in the upper well of a transwell. After 3±3.5 hr incubation,
tained by drawing up and down using a syringe with a 23G needle. the number of migratory cells to the lower of transwell was counted
Cells were layered onto Lymphoprep solution (1.077 g/ml) (Ny- by using hemocytometer. Four micrograms per milliliter of anti-
comed, Oslo, Norway), and cells in the light density fraction were WECHE antibody was added to the upper of transwell. Five hundred
collected. Cells were cultured in HAVA medium overnight to deplete nanograms per milliliter of SDF-1a (R&D Systems) was used as a
adherent cells. Nonadherent cells were collected, suspended with positive control.
Leibovitz's L-15 medium (L-15) (GIBCO±BRL)/2% FBS containing
Fc block (CD16/CD32) (1:200) (PharMingen), and incubated on ice Acknowledgments
for 15 min. Lineage cocktail was added and incubated on ice for 30
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